Showing results (41-50 of 322) with videos related to

Sort By:
Pageof 33
Medicina (Kaunas, Lithuania)|February 26, 2025
Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?José María Mora-Luján, Abelardo Montero, Francesc Formiga, et al.
Geriatrics & Gerontology International|January 19, 2011
Serum high-density lipoprotein cholesterol levels, their relationship with baseline functional and cognitive status, and their utility in predicting mortality in nonagenariansFrancesc Formiga, Assumpta Ferrer, David Chivite, et al.
Cardiology|September 28, 2006
Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failureFrancesc Formiga, David Chivite, Nicolas Manito, et al.
Aging Clinical and Experimental Research|August 30, 2007
Predictive items of one-year mortality in nonagenarians. The NonaSantfeliu StudyFrancesc Formiga, Assumpta Ferrer, Jordi Mascaró, et al.
European Journal of Public Health|June 4, 2008
Predictive items of functional decline and 2-year mortality in nonagenarians--the NonaSantfeliu studyAssumpta Ferrer, Francesc Formiga, Domingo Ruiz, et al.
Age and Ageing|July 16, 2015
Potentially inappropriate prescribing detected by STOPP-START criteria: are they really inappropriate?Isabel Lozano-Montoya, Manuel Vélez-Diaz-Pallarés, Eva Delgado-Silveira, et al.
Archives of Gerontology and Geriatrics|April 22, 2008
Ambulatory blood pressure monitoring (ABPM) in nonagenariansFrancesc Formiga, Assumpta Ferrer, Javier Sobrino, et al.
European Journal of Internal Medicine|November 29, 2012
Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix studyFrancesc Formiga, Assumpta Ferrer, Hector Sanz, et al.
European Journal of Preventive Cardiology|November 23, 2017
Secondary prevention programme of ischaemic heart disease in the elderly: A randomised clinical trialElisenda Marcos-Forniol, José F Meco, Emili Corbella, et al.
Journal of the American Medical Directors Association|May 31, 2011
High rate of anticoagulation therapy in oldest old subjects with atrial fibrillation: the Octabaix studyFrancesc Formiga, Assumpta Ferrer, Daniel Mimbrera, et al.
Pageof 33